首页|期刊导航|国际肝胆胰疾病杂志（英文版）|Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma:A multicenter study

Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma:A multicenter study

Yuan Cheng Zhong Chen Xiang-Cheng Li Jun-Ying Wang You Lu Yong-Xiang Xia Hui Zhao Qi Wang Xiao-Li Zhu Qing-Quan Zu Hui-Kai Li

国际肝胆胰疾病杂志（英文版）2025，Vol.24Issue(6)：656-665,10.

国际肝胆胰疾病杂志（英文版）2025，Vol.24Issue(6)：656-665,10.DOI:10.1016/j.hbpd.2025.09.004

Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma:A multicenter study

Yuan Cheng ¹Zhong Chen ²Xiang-Cheng Li ³Jun-Ying Wang ⁴You Lu ⁵Yong-Xiang Xia ³Hui Zhao ⁶Qi Wang ⁷Xiao-Li Zhu ⁸Qing-Quan Zu ⁹Hui-Kai Li¹⁰

作者信息

1. Department of Medical Oncology,Jinling Hospital,Affiliated Hospital of Medical School,Nanjing University,Nanjing 210002,China
2. Department of Hepatobiliary and Pancreatic Surgery,Affiliated Hospital of Nantong University,Nantong 226001,China
3. Hepatobiliary Center,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China
4. Center of Interventional Radiology&Vascular Surgery,Department of Radiology,Cultivation and Construction Site of the State Key Laboratory of Intelligent Imaging and Interventional Medicine(Southeast University),Basic Medicine Research and Innovation Center of Ministry of Education,Zhongda Hospital,Medical School,Southeast University,Nanjing 210009,China
5. Department of Interventional Radiology,Jiangsu Cancer Hospital,The Affiliated Cancer Hospital of Nanjing Medical University,Jiangsu Institute of Cancer Research,Nanjing 210009,China
6. Department of Interventional&Vascular Surgery,Affiliated Hospital of Nantong University,Nantong 226001,China
7. Department of Interventional Radiology,The Third Affiliated Hospital of Soochow University,The First People's Hospital of Changzhou,Changzhou 213003,China
8. Department of Interventional Radiology,The First Affiliated Hospital of Soochow University,Suzhou 215006,China
9. Department of Interventional Radiology,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China
10. Department of Hepatobiliary and Pancreatic Oncology,Tianjin Cancer Hospital Airport Hospital,Tianjin 300308,China||Department of Hepatobiliary Cancer,Liver Cancer Center,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
折叠

摘要

关键词

Hepatocellular carcinoma/Immune checkpoint inhibitor/Regorafenib/Second-line therapy

Key words

Hepatocellular carcinoma/Immune checkpoint inhibitor/Regorafenib/Second-line therapy

引用本文复制引用

Yuan Cheng,Zhong Chen,Xiang-Cheng Li,Jun-Ying Wang,You Lu,Yong-Xiang Xia,Hui Zhao,Qi Wang,Xiao-Li Zhu,Qing-Quan Zu,Hui-Kai Li..Efficacy of regorafenib following first-line immune checkpoint inhibitor failure in patients with advanced hepatocellular carcinoma:A multicenter study[J].国际肝胆胰疾病杂志（英文版）,2025,24(6):656-665,10.

基金项目

This study was supported by a grant from the Zhongda Hospi-tal Affiliated to Southeast University,Jiangsu Province High-Level Hospital Construction Funds(No.YKK24270). （No.YKK24270）

国际肝胆胰疾病杂志（英文版）

ISSN：1499-3872

访问量0

下载量0

段落导航